Basic Information
RNALocate ID: | RLID-D:11001436 |
RNA Symbol: | hsa-miR-769-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-769-3p |
RNA ID: | miRBase:MIMAT0003887 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003526 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID-D:11000561 | Microvesicle | Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-769-3p | Oral squamous cell carcinoma | MNDR-E-MI-69277 |
MNDR | hsa-miR-769-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-69278 |
MNDR | hsa-miR-769-3p | Lymphoma | MNDR-E-MI-69279 |
MNDR | hsa-miR-769-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-69280 |
MNDR | hsa-miR-769-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-69281 |
MNDR | hsa-miR-769-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-69282 |
MNDR | hsa-miR-769-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-69283 |
MNDR | hsa-miR-769-3p | Her2-receptor positive breast cancer | MNDR-E-MI-69284 |
MNDR | hsa-miR-769-3p | Breast cancer luminal | MNDR-E-MI-69285 |
MNDR | hsa-miR-769-3p | Prostate cancer | MNDR-E-MI-69286 |
MNDR | hsa-miR-769-3p | Gastric cancer | MNDR-E-MI-69287 |
MNDR | hsa-miR-769-3p | Alzheimer disease | MNDR-E-MI-69288 |
MNDR | hsa-miR-769-3p | Leukemia | MNDR-E-MI-69289 |
MNDR | hsa-miR-769-3p | Huntington disease | MNDR-E-MI-69290 |
MNDR | hsa-miR-769-3p | Moyamoya disease | MNDR-E-MI-69291 |
MNDR | hsa-miR-769-3p | Lung cancer | MNDR-E-MI-69292 |
MNDR | hsa-miR-769-3p | Parkinson disease | MNDR-E-MI-69293 |
MNDR | hsa-miR-769-3p | Basal-like breast cancer | MNDR-E-MI-69294 |
MNDR | hsa-miR-769-3p | Pancreatic cancer | MNDR-E-MI-69295 |
MNDR | hsa-miR-769-3p | Melanoma | MNDR-E-MI-69296 |
MNDR | hsa-miR-769-3p | Rectum adenocarcinoma | MNDR-E-MI-69297 |
MNDR | hsa-miR-769-3p | Nephroblastoma | MNDR-E-MI-69298 |
MNDR | hsa-miR-769-3p | Colon cancer | MNDR-E-MI-69299 |
MNDR | hsa-miR-769-3p | Colon adenocarcinoma | MNDR-E-MI-69300 |
MNDR | hsa-miR-769-3p | Familial ovarian cancer | MNDR-E-MI-69301 |
MNDR | hsa-miR-769-3p | Prostate adenocarcinoma | MNDR-E-MI-69302 |
MNDR | hsa-miR-769-3p | Carcinoma ductal breast | MNDR-E-MI-69303 |
MNDR | hsa-miR-769-3p | Glioblastoma | MNDR-E-MI-69304 |
MNDR | hsa-miR-769-3p | Astrocytoma | MNDR-E-MI-69305 |
MNDR | hsa-miR-769-3p | Malignant glioma | MNDR-E-MI-69306 |
MNDR | hsa-miR-769-3p | Osteosarcoma | MNDR-E-MI-69307 |
MNDR | hsa-miR-769-3p | Lung squamous cell carcinoma | MNDR-E-MI-69308 |
MNDR | hsa-miR-769-3p | Lung adenocarcinoma | MNDR-E-MI-69309 |
MNDR | hsa-miR-769-3p | Bladder urothelial carcinoma | MNDR-E-MI-69310 |
MNDR | hsa-miR-769-3p | Pancreatic adenocarcinoma | MNDR-E-MI-69311 |
MNDR | hsa-miR-769-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-69312 |
MNDR | hsa-miR-769-3p | Biliary tract cancer | MNDR-E-MI-69313 |
MNDR | hsa-miR-769-3p | Cholangiocarcinoma | MNDR-E-MI-69314 |
MNDR | hsa-miR-769-3p | Synovial sarcoma | MNDR-E-MI-69315 |
MNDR | hsa-miR-769-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-69316 |
MNDR | hsa-miR-769-3p | Serrated adenoma | MNDR-E-MI-69317 |
MNDR | hsa-miR-769-3p | Breast invasive carcinoma | MNDR-E-MI-69318 |
MNDR | hsa-miR-769-3p | Hepatocellular carcinoma | MNDR-E-MI-69319 |
MNDR | hsa-miR-769-3p | Familiar ovarian carcinoma | MNDR-E-MI-69320 |
MNDR | hsa-miR-769-3p | Barrett's adenocarcinoma | MNDR-E-MI-69321 |
MNDR | hsa-miR-769-3p | Hodgkin lymphoma | MNDR-E-MI-69322 |
MNDR | hsa-miR-769-3p | Acute myelocytic leukemia | MNDR-E-MI-69323 |
MNDR | hsa-miR-769-3p | Nasopharynx carcinoma | MNDR-E-MI-69324 |
MNDR | hsa-miR-769-3p | Lupus vulgaris | MNDR-E-MI-69325 |
MNDR | hsa-miR-769-3p | Nasopharyngeal cancer | MNDR-E-MI-69326 |
MNDR | hsa-miR-769-3p | Barrett's carcinogenesis | MNDR-E-MI-69327 |
MNDR | hsa-miR-769-3p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-69328 |
TOP